# Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis

> **NCT01895244** · PHASE2 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 44 (actual)

## Conditions studied

- Scleroderma
- Cardiac Involvement
- Autologous Stem Cell Transplantation

## Interventions

- **DRUG:** Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells

## Key facts

- **NCT ID:** NCT01895244
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2021-09
- **Final completion:** 2024-06
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01895244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01895244, "Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01895244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*